Day: January 27, 2022

Results Support Favorable Safety and Tolerability Profile and Target Engagement of GB0139 and Potential for GB0139 in Severe Lung Disease Company Provides Update on GALACTIC-1 Trial BOSTON, Jan. 27, 2022 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced the publication of the full results of an investigator-initiated open and randomized trial to evaluate Galecto’s inhaled galectin-3 inhibitor, GB0139, in hospitalized patients with COVID-19 infection who required oxygen but not mechanical ventilation, compared to patients only on standard of care. Galectin-3 plays a key role in COVID-19-related acute lung injury, cytokine storm, T-cell exhaustion and organ micro-thrombosis, and the results from this trial...

TORONTO, Ontario and CAMBRIDGE, Mass., Jan. 27, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it has appointed Dr. Cheryl Wellington to its scientific advisory board (SAB). Dr. Cheryl Wellington, Professor of Pathology and Laboratory Medicine at the University of British Columbia (UBC), has built an internationally recognized research program that focuses on neurological diseases, with a particular emphasis on Alzheimer’s Disease (AD) and Traumatic Brain Injury (TBI).  “We are delighted to welcome Dr. Wellington to the ProMIS SAB,” stated Dr. Neil Cashman, ProMIS’ Chief Scientific...

THE WOODLANDS, Texas, Jan. 27, 2022 (GLOBE NEWSWIRE) — ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ: CHX) announced today that UNBRIDLED® ESP Systems has introduced the HIGH RISE™ series pump line, which is engineered to significantly improve electrical submersible pumping (ESP) system performance and longevity while also meaningfully reducing the carbon footprint of ESP operations. HIGH RISE pumps feature patented Oculus™ technology, which allows the pumps to achieve up to 33% greater lift per unit length of pump. Higher lift per stage means fewer components in the well and faster installs to minimize rig time while also reducing the overall carbon footprint of an ESP system. The HIGH RISE pump series also covers an extended production range from 200 to 7,500 BPD. “The Oculus technology feature in our HIGH RISE...

NEW YORK, Jan. 27, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Alpine Summit Energy Partners, Inc. (TSX-V: ALPS.U; OTCQX: ASEPF), an energy developer and financial company focused on maximizing growth and return on equity via improved access to wellhead economics, has qualified to trade on the OTCQX® Best Market. Alpine Summit Energy Partners, Inc. upgraded to OTCQX from the OTCQB® Venture Market. Alpine Summit Energy Partners, Inc. begins trading today on OTCQX under the symbol “ASEPF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX,...

TORONTO and KNOXVILLE, Tenn., Jan. 27, 2022 (GLOBE NEWSWIRE) — Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR, OTCQB: SAENF) is pleased to announce it has signed a contract with AESSEAL, a specialist in the design and manufacture of mechanical seals and support systems, for a 526-kilowatt (“kW”) roof mount solar system at AESSEAL’s U.S. headquarters in Rockford, Tennessee. Solar Alliance will design, engineer and install the project, which is scheduled to begin construction in April and is targeted for completion by the end of October 2022. “Solar Alliance is proud to have been selected to deliver this 526-kW project for AESSEAL in Tennessee,” said Solar Alliance CEO Myke Clark. “This solar project is a testament to AESSEAL’s commitment to sustainable business practices and also to reducing their operating...

Quarterly Cash Dividend Increased to $0.16 per Share Fourth Quarter HighlightsNet income of $13.6 million, or $0.47 per diluted share; return on average assets (ROAA) of 1.26%; return on average stockholders’ equity (ROAE) of 13.15%; and return on average tangible common equity (ROATCE)(1) of 14.24% Adjusted net income(1) of $14.2 million; or $0.49 per diluted share; adjusted ROAA(1) of 1.32%; adjusted ROAE(1) of 13.70%; and adjusted ROATCE(1) of 14.83%(1)   See “Reconciliation of Non-GAAP Financial Measures” below for reconciliation of non-GAAP financial measures to their most closely comparable GAAP financial measures. BLOOMINGTON, Ill., Jan. 27, 2022 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial” or “HBT”), the holding company for Heartland Bank and Trust Company,...

NEW YORK, Jan. 27, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Numinus Wellness Inc. (TSX: NUMI; OTCQX: NUMIF), an integrated mental health company, has qualified to trade on the OTCQX® Best Market. Numinus Wellness Inc. upgraded to OTCQX from the Pink® market. Numinus Wellness Inc. begins trading today on OTCQX under the symbol “NUMIF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting...

CHICAGO, Jan. 27, 2022 (GLOBE NEWSWIRE) — Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) (“Chicago Atlantic” or the “Company”), a commercial real estate finance company, announced today it funded $10 million as the initial advance of a new $25 million senior secured credit facility to Sanctuary Medicinals LLC (“Sanctuary”) to support their retail and cultivation expansion in Florida. Headquartered in Apopka, Florida, Sanctuary operates a premier cultivation and processing facility with 5 operational dispensaries and plans to open more than 18 additional locations in Florida during 2022. “Sanctuary is a best-in-class operator who has proven their ability to obtain highly coveted licenses and build preeminent retail and cultivation assets at incredible speed,” said Tony Cappell, Chief Executive...

TORONTO, Jan. 27, 2022 (GLOBE NEWSWIRE) — Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF) today releases an open letter to shareholders from the Company’s President and Chief Executive Officer, Justin Reid. While a copy of the letter is presented in this press release, the original document can be found on our website HERE. Dear Shareholders, 2021 was an intensive year of work by the Troilus team as it continued to solidify the foundations and advance our mining project, which we believe has the potential to be a cornerstone Canadian mine for decades to come. On all fronts, our project and our team have never been in a stronger position. First and foremost, we had great success with the drill bit and in the field, while our expanded engineering team has been busy calculating trade-offs and analyzing options...

ENGLEWOOD CLIFFS, N.J., Jan. 27, 2022 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net income available to common stockholders of $31.3 million for the fourth quarter of 2021, compared with $32.1 million for the third quarter of 2021 and $25.6 million for the fourth quarter of 2020. Diluted earnings per share were $0.79 for the fourth quarter of 2021 compared with $0.80 for the third quarter of 2021 and $0.64 for the fourth quarter of 2020. The $0.8 million decrease in net income available to common stockholders and $0.01 decrease in diluted earnings per share versus the third quarter of 2021 were primarily due to $1.7 million in preferred dividends, a $1.4 million increase in income tax expense and a $0.2 million decrease...